nausea, diarrhea, constipation, and mild stomach discomfort typically more pronounced during dose escalation and tending to lessen with time
Cagrilintide works in a way that's somewhat different from GLP-1 drugs, which also are used for weight management
Nor did we have information about changes in CGM metrics
Yoshida et al., 1998, 1999)
Hospital systems were comparably affected, for example, UPMC out of Pittsburgh posted an even larger loss of about $370 million over the same term, which it attributed to increased medical utilization and pharmacy costs, while Highmark Health - also of Pittsburgh - despite avoiding operational losses, reported a significant decline in operating gains in 2024 relative to 2023, which administrators blame on high prescription drug costs - most notably GLP-1s